ePRO, ePatient Diaries, and eCOA Market is expected to reach US$ 4,130.35 Mn by 2028

by Sameer Joshi or 24-May-2021

A PHP Error was encountered

Severity: Warning

Message: Trying to access array offset on value of type null

Filename: views/press_details.php

Line Number: 14

Backtrace:

File: /home/reportsweb/public_html/application/views/press_details.php
Line: 14
Function: _error_handler

File: /home/reportsweb/public_html/application/controllers/Press_controller.php
Line: 112
Function: view

File: /home/reportsweb/public_html/index.php
Line: 316
Function: require_once

Market for Web-Based Delivery Segment to Grow Significantly During 2021–2028
 
According to the latest study on “ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Solution, Modality, and End User,” the market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.1% during 2021–2028. The report highlights trends prevailing in the market and the factors driving and restraining the market growth.
 
The usage of electronic Clinical Outcome Assessment (eCOA) is a push toward adapting the ‘new normal’ as it is a method to gather patient data electronically by using technologies such as smart home devices, handheld monitors, wearables, e-diaries, tablets, and web servers to allow the stakeholders (patients, healthy volunteers, investigators and caregivers) in the trials to report outcomes directly and digitally. Although historically COA was only related to the evaluation of Patient-Related Outcomes (PRO), the FDA has now broadened the definition to include PerfO, ClinRO, and ObsRO along with PRO. In simple terms, when the above parameters are reported electronically, they fit under the eCOA spectrum. 
 
eCOA/ePRO platform has substantial benefits for sponsors and CROs, as it reduces administrative burden, mitigates cost, and fastens trials. Such system shows strong results with fewer errors and discrepancies, improved data quality, clearer signals, and standardized accurate studies. The factors such as the increasing adoption of EHR and government regulations mandating the maintenance of health records drive the growth of the ePRO, epatient diaries, and eCOA market.
 
Based on modality, the ePRO, epatient diaries, and eCOA market is bifurcated into computer and mobile devices. The mobile devices segment held a larger share of the market in 2020. Also, the same segment is estimated to register a higher CAGR in the market during the forecast period.
 
Bracket Global LLC (Signant Health), CRF Health, Inc., ERT Clinical, Medidata Solutions, Inc., ArisGlobal LLC, Health Diary, Pte., Ltd., ICON Plc, PAREXEL International Corporation , OmniComm Systems, Inc., Kayentis, and eClinical Solutions LLC. are among the major companies operating in the global ePRO, epatient diaries, and eCOA market.
 
The report segments global ePRO, epatient diaries, and eCOA market as follows:
 
By Type of Solution
  • eClinical Outcome Assessments
  • ePatient Reported Outcomes
  • Clinician Reported Outcomes
  • Observer Reported Outcomes
  • Performance Outcomes
  • ePatient Diaries 
By Modality
  • Computer 
  • Mobile Devices
By End User
  • Clinical Trial Sponsors
  • Contract Research Organizations
  • Hospitals
  • Academic Institutes
  • Pharmaceutical Companies
  • Others 
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
      • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa 
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com